Not applicableLooking for participantsNCT07648602What this trial is testingPPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional StudyWho this might be right forPsoriasis CorEvitas 2,500
Not applicableStudy completedNCT04826536What this trial is testingTreatment Patterns and Clinical Outcomes of Psoriasis in JapanWho this might be right forPsoriasis Bristol-Myers Squibb 114
Not applicableLooking for participantsNCT06029257What this trial is testingTildrakizumab in the Treatment of Genital Psoriasis (CZATCH-Genital-PsO)Who this might be right forGenital Psoriasis Almirall, S.A. 110
Not applicableActive Not RecruitingNCT06897722What this trial is testingEvaluation of TNF-α, IL-17A, and YKL-40 in GCF and Serum of Psoriasis Patients and Healthy ControlsWho this might be right forPsoriasis (PsO)Periodontal Disease Zhala Vatankha Sain 100
Large-scale testing (Phase 3)UnknownNCT06299982What this trial is testingAn Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsOWho this might be right forPlaque Psoriasis Patients Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 750
Large-scale testing (Phase 3)Study completedNCT02489227What this trial is testingComparison of CHS-1420 Versus Humira in Subjects With Chronic Plaque PsoriasisWho this might be right forPlaque Psoriasis Coherus Oncology, Inc. 545
Testing effectiveness (Phase 2)Study completedNCT04603027What this trial is testingStudy Investigating the Effect of EDP1815 in the Treatment of Mild to Moderate Plaque PsoriasisWho this might be right forPsoriasisPlaque Psoriasis Evelo Biosciences, Inc. 249
Not applicableLooking for participantsNCT07370766What this trial is testingImpact of Tildrakizumab on Patient Reported Outcomes in Patients With Moderate-to-severe Psoriasis in CanadaWho this might be right forPsoriasis (PsO)Moderate to Severe Psoriasis Chronicle Academy 80
Large-scale testing (Phase 3)Study completedNCT02326272What this trial is testingEvaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)Who this might be right forPsoriasisPlaque Psoriasis UCB Biopharma S.P.R.L. 227
Not applicableEnded earlyNCT06715254What this trial is testingA Real-world Study of Tuberculosis Incidence in AS, PsA, or PsO Patients Treated With Secukinumab in BrazilWho this might be right forTuberculosis Novartis Pharmaceuticals 152
Post-approval studies (Phase 4)Study completedNCT01587755What this trial is testingOptimising Outpatient Care in Mild to Moderate Psoriasis (PSO-TOP)Who this might be right forMild to Moderate Psoriasis Kristian Reich, MD 1,852
Very early researchLooking for participantsNCT07169019What this trial is testingMicrobiome and Clinical Response to Probiotics and Methotrexate in Early Psoriasis: a Pilot StudyWho this might be right forPsoriasis (PsO) Alexandria University 24
Not applicableLooking for participantsNCT07615712What this trial is testingPPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional StudyWho this might be right forPsoriasis CorEvitas 2,500
Early research (Phase 1)Study completedNCT04163016What this trial is testingA Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)Who this might be right forRheumatoid ArthritisPsoriatic ArthritisCrohn's Disease+2 more UCB Biopharma SRL 22
Not applicableLooking for participantsNCT02707341What this trial is testingThe CorEvitas Psoriasis (PSO) RegistryWho this might be right forPsoriasis CorEvitas 10,000
Not applicableLooking for participantsNCT06987292What this trial is testingA Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)Who this might be right forPsoriasis (PsO)EnthesitisPsoriasis Arthritis+1 more The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 50
Not applicableStudy completedNCT05547490What this trial is testingAssess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque PsoriasisWho this might be right forPsoriasis Bristol-Myers Squibb 3,506
Large-scale testing (Phase 3)Study completedNCT03410992What this trial is testingA Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque PsoriasisWho this might be right forChronic Plaque PsoriasisModerate to Severe Chronic Plaque PsoriasisPsoriatic Arthritis UCB Biopharma SRL 435
Testing effectiveness (Phase 2)Looking for participantsNCT06592274What this trial is testingHB0017 in Psoriasis PatientsWho this might be right forPsoriasis (PsO) Huabo Biopharm Co., Ltd. 200
Not applicableLooking for participantsNCT07021495What this trial is testingSKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)Who this might be right forChronic Spontaneous Urticaria (CSU)Hidradenitis Suppurativa (HS)Psoriasis (PsO)+2 more Leiden University Medical Center 840